Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis.

Abstract

Clotrimazole 1% (Canesten) cream was used in a trial comprising 138 men with candidal balanitis. Eighty-six (91%) out of 94 men were asymptomatic after seven days and 57 (98%) of 58 men were asymptomatic after three weeks' treatment. After seven days, Candida albicans could no longer be cultured from 86 (90%) of 96 men, nor from 55 (95%) of 58 men three weeks after treatment. Microscopical examination gave varying results. Fifteen (10.9%) of 138 men were found to have diabetes mellitus; this group was significantly older than the non-diabetics. It is concluded that treatment with clotrimazole for seven days is effective in the treatment of candidal balanitis.

• Authors: M A Waugh, E G Evans, K C Nayyar, R Fong
• Journal: The British journal of venereal diseases (Br J Vener Dis) Vol. 54 Issue 3 Pg. 184-6 (Jun 1978) ISSN: 0007-134X [Print] England
• PMID: 656891 (Publication Type: Journal Article)

Chemical References

• Imidazoles
• Clotrimazole

Topics

• Adolescent
• Adult
• Aged
• Balanitis (drug therapy, etiology)
• Candidiasis (complications, drug therapy)
• Clotrimazole (therapeutic use)
• Diabetes Complications
• Humans
• Imidazoles (therapeutic use)
• Male
• Middle Aged